Morningstar's Mansueto Sells $17M in MORN, Keeps 37.5%

Every trading day through May 2026, Joe Mansueto sold 7,250 shares of Morningstar — the company he founded in a Chicago apartment in 1984 with $80,000 and a conviction that ordinary investors deserved institutional-grade fund research. The May tally came to exactly 100,000 shares for about $17.2 million. And yet, after all of it, the executive chairman still controls more than a third of the company. This is what disciplined founder diversification looks like: a fixed daily slice, run on autopilot, that barely scratches a stake measured in the billions.

The cadence is the giveaway. Selling the identical 7,250-share block on up days and down days, week after week, is the signature of a prearranged Rule 10b5-1 trading plan rather than any read on Morningstar's prospects. The dollar figures drifted with the share price — roughly $1.21 million on May 1, about $1.25 million by May 21 — but the share count never moved. Mansueto's most recent Form 4, accession 0001324069-26-000030, records 8,043,492 shares still held directly after his May 22 sale. The complete, multi-thousand-transaction record lives in Mansueto's Form 4 trading history.

The 37.5% that anchors everything

The direct Form 4 figure understates how much of Morningstar Mansueto actually controls. His own Schedule 13G/A, filed February 12, 2026, reports beneficial ownership of 14,909,759 shares — a 37.5% stake that makes him, by an enormous margin, the company's controlling shareholder. A related family filing from Daniel Mansueto disclosed an additional 9.5% (3,757,306 shares) the same day. Put together, the Mansueto family's grip on Morningstar's float is the central fact of the stock: no activist, no acquirer, and no proxy contest happens without the founder's say-so.

That context reframes the selling entirely. Over the visible record stretching back to early 2025, Mansueto sold roughly 497,000 shares for about $123 million, and his career Morningstar sales now exceed $1.95 billion. Those are staggering absolute numbers — and still a rounding error against a 37.5% position. A founder who has sold nearly $2 billion in stock over his lifetime while remaining the dominant holder is not exiting; he is converting a sliver of an illiquid, hyper-concentrated fortune into diversified wealth on a schedule, the textbook reason 10b5-1 plans exist.

Philanthropy in the mix

The recent filings also include code-G transactions — gifts, not market sales. Mansueto and his wife are signatories of the Giving Pledge, and charitable transfers of MORN stock are a recurring feature of his Form 4 history. These are not sentiment signals; a gift moves shares to a foundation or recipient and carries no view on valuation. Lumping them in with open-market sales would overstate the "selling," which is precisely the kind of distinction that separates a data-driven read from a headline. The relevant disposals for market-signal purposes are the systematic code-S sales, and even those are plan-driven.

The business behind the stock

Morningstar enters this selling window in strong shape. The company grew operating and adjusted operating income more than 30% in the first quarter of 2026 while reducing shares outstanding by roughly 4% through buybacks — a combination that mechanically boosts per-share value even as the founder trims. Under CEO Kunal Kapoor, Morningstar has leaned into recurring-revenue franchises in credit ratings, indexes, and data, the same high-margin information-services model that has rerated peers across the sector.

That peer group is the right lens for MORN. Morningstar competes for the financial-data dollar against MSCI in indexes, S&P Global and Moody's in ratings and analytics, and FactSet in workstation data. All trade as premium subscription-economics compounders, which is why a founder-chairman steadily diversifying out of a single-name concentration — however strong the franchise — is simple portfolio prudence rather than a warning. Among institutional holders, active managers such as Wellington Management hold MORN as a discretionary position, a cleaner read on conviction than the index complexes like BlackRock that hold it to match benchmark weights.

What to watch next

Three markers will tell investors whether anything has changed. First, the plan cadence: if the next batch of Form 4s shows the daily slice stepping up from 7,250 shares or the selling extending into new months, that signals a refreshed and larger 10b5-1 program. Second, any move below the 37.5% threshold that would loosen family control — at the current pace, that is years away, but it is the number that matters for any future strategic scenario. Third, the hard catalyst: Morningstar's next quarterly results, due July 29, 2026, which will test whether the 30%-plus profit growth can persist. Until the data says otherwise, Mansueto's May selling is exactly what it appears to be — a founder monetizing a fraction of an outsized stake on a calendar, while keeping his hand firmly on the company. Track any change in Mansueto's insider transaction record as the next filings post.

FAQ

Why is Morningstar founder Joe Mansueto selling MORN stock?

Mansueto sold a fixed 7,250 shares on nearly every trading day in May 2026, the signature of a prearranged Rule 10b5-1 plan for diversification rather than a discretionary call. He still controls 37.5% of Morningstar, so the sales are a trim, not an exit.

How much of Morningstar does Joe Mansueto own?

Mansueto's Schedule 13G/A filed February 12, 2026 reports beneficial ownership of 14,909,759 shares, a 37.5% controlling stake. A related family filing disclosed an additional 9.5%. He held 8,043,492 shares directly per his latest Form 4.

How much MORN stock did Mansueto sell in May 2026?

Mansueto sold 100,000 Morningstar shares for about $17.2 million in May 2026, almost all in 7,250-share daily increments. His career Morningstar sales exceed $1.95 billion.

When does Morningstar report earnings?

Morningstar's next quarterly results are due July 29, 2026. The company grew operating income more than 30% in the first quarter of 2026 while reducing shares outstanding by roughly 4%.